Obesity Is Associated with Changes in Laboratory Biomarkers in Chilean Patients Hospitalized with COVID-19.

Sharon Viscardi Luis MarileoHugo DelgadoAndrés San MartínLoreto HernándezPaola GarcésDina Guzmán-OyarzoRodrigo BoguenGustavo MedinaPablo LetelierInes Villano Neftalí H Guzmán

Published in: Journal of clinical medicine (2023)

Patients with obesity hospitalized for COVID-19 present marked elevations of inflammatory and hemostasis parameters, with a correlation between obesity, changes in laboratory biomarkers, and the risk of adverse clinical outcomes also observed.

Keyphrases

insulin resistance
metabolic syndrome
weight loss
high fat diet induced
type diabetes
weight gain
sars cov
end stage renal disease
chronic kidney disease
coronavirus disease
newly diagnosed
oxidative stress
skeletal muscle
physical activity
body mass index
peritoneal dialysis